Company / Current Assets per Share
10x Genomics, Inc. Current Assets per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$5.60
FY2025
5-year range
$4.91 / $6.89
FY2021-FY2025
Trend
+14.1%
vs FY2024
Sector context
#128 of 163
Health Care
What the data says
10x Genomics, Inc.'s current assets per share of $5.60 is lower than 79% of companies in the Health Care sector (FY2025). Current Assets per Share returned to growth in FY2025 after 5 years of decline, reaching $5.60.
Based on SEC 10-K filings.
5.60 in FY2025 with a 5-year CAGR of -7.0%.
Improved from $5.17 to $5.60 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -0.3%
- 5-Year CAGR
- -7.0%
- 10-Year CAGR
- -
Sector benchmark
Bottom 21% in Health CareTop 79% of 163This company $5.60 Sector average $52.97
▼
-89.4% below sector average
Key checks
Key Insights
- In FY2025, current assets per share increased 14.1% year-over-year.
- Ranks #128 out of 163 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2019.
- Lowest current assets per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -29.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.60 | +14.1% |
| FY2024 | $4.91 | -5.2% |
| FY2023 | $5.17 | -8.3% |
| FY2022 | $5.64 | -18.1% |
| FY2021 | $6.89 | -14.4% |
| FY2020 | $8.05 | -75.7% |
| FY2019 | $33.05 | +316.6% |
| FY2018 | $7.93 | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026